Literature DB >> 25876990

Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology.

Gail L Jones1, Andrew Will2, Graham H Jackson1, Nicholas J A Webb2, Simon Rule3.   

Abstract

Entities:  

Keywords:  chemotherapy; clinical haematology; haematological malignancy; haematological oncology; tumour lysis syndrome

Mesh：

Year:  2015        PMID： 25876990     DOI： 10.1111/bjh.13403

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  34 in total

1.  Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia.

Authors:  Kirsten Fischer; Othman Al-Sawaf; Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Reply to comments from Vincent et al.

Authors:  Kazuo Tamura
Journal:  Int J Clin Oncol       Date:  2017-02-02       Impact factor: 3.402

3.  Understanding tumor lysis syndrome.

Authors:  Lara Zafrani; Emmanuel Canet; Michael Darmon
Journal:  Intensive Care Med       Date:  2019-09-13       Impact factor: 17.440

4.  Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.

Authors:  Kazuo Tamura; Yasukazu Kawai; Toru Kiguchi; Masataka Okamoto; Masahiko Kaneko; Makoto Maemondo; Kenichi Gemba; Katsumichi Fujimaki; Keita Kirito; Tetsuya Goto; Tomoaki Fujisaki; Kenji Takeda; Akihiro Nakajima; Takanori Ueda
Journal:  Int J Clin Oncol       Date:  2016-03-26       Impact factor: 3.402

Review 5.  How I treat acute myeloid leukemia presenting with preexisting comorbidities.

Authors:  Yishai Ofran; Martin S Tallman; Jacob M Rowe
Journal:  Blood       Date:  2016-05-27       Impact factor: 22.113

6.  Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.

Authors:  Alexander Langridge; Kathryn Musgrave; Yogesh Upadhye
Journal:  BMJ Case Rep       Date:  2016-03-09

7.  Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.

Authors:  Helena S Gouveia; Sílvia O Lopes; Ana Luísa Faria
Journal:  BMJ Case Rep       Date:  2018-03-15

Review 8.  Management of Hyperleukocytosis.

Authors:  Antonio Ruggiero; Daniela Rizzo; Maria Amato; Riccardo Riccardi
Journal:  Curr Treat Options Oncol       Date:  2016-02

9.  Evaluation of Rasburicase Use in the Fraser Health Authority: A Retrospective Review.

Authors:  Jia Shermaine Ngo; Man Hon Mark Ho
Journal:  Can J Hosp Pharm       Date:  2018-08-31

10.  Clinical Interventions to Prevent Tumour Lysis Syndrome in Hematologic Malignancy: A Multisite Retrospective Chart Review.

Authors:  Sarah McKenna; Alexandra Cheung; Amanda Wolfe; Brenda L Coleman; Michael E Detsky; Laveena Munshi; Dawn Maze; Lisa Burry
Journal:  Can J Hosp Pharm       Date:  2019-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.